- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2047-9158
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Role of BACE1 in Alzheimer’s synaptic function ; volume:6 ; number:1 ; day:30 ; month:8 ; year:2017 ; pages:1-8 ; date:12.2017
Translational neurodegeneration ; 6, Heft 1 (30.8.2017), 1-8, 12.2017
- Schlagwort
-
Gehirn
Zentralnervensystem
- Urheber
-
Das, Brati
- Beteiligte Personen und Organisationen
-
Yan, Riqiang
SpringerLink (Online service)
- DOI
-
10.1186/s40035-017-0093-5
- URN
-
urn:nbn:de:1111-201711046995
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:33 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Das, Brati
- Yan, Riqiang
- SpringerLink (Online service)
Ähnliche Objekte (12)
Function and substrates of the Alzheimer´s disease protease BACE1
BACE1 inhibitor drugs in clinical trials for Alzheimer’s disease
The Alzheimer's disease β-secretase enzyme, BACE1
BACE1, the Alzheimer’s beta-secretase enzyme, in health and disease
Platelet BACE1 levels as a possible biomarker for Alzheimer’s disease
Stepping closer to treating Alzheimer’s disease patients with BACE1 inhibitor drugs
The role of pathological tau in synaptic dysfunction in Alzheimer’s diseases
40 Hz light preserves synaptic plasticity and mitochondrial function in Alzheimer’s disease model
Sorting out the cell biology of Alzheimer’s disease: focus on BACE1 and APP
CSF levels of the BACE1 substrate NRG1 correlate with cognition in Alzheimer’s disease
Substrates and functions of the Alzheimer’s disease proteases ADAM10, BACE1, and MT5-MMP
BACE1, the Alzheimer's beta-secretase enzyme, in health and disease
Function and substrates of the Alzheimer´s disease protease BACE1
BACE1 inhibitor drugs in clinical trials for Alzheimer’s disease
The Alzheimer's disease β-secretase enzyme, BACE1
BACE1, the Alzheimer’s beta-secretase enzyme, in health and disease
Platelet BACE1 levels as a possible biomarker for Alzheimer’s disease
Stepping closer to treating Alzheimer’s disease patients with BACE1 inhibitor drugs
The role of pathological tau in synaptic dysfunction in Alzheimer’s diseases
40 Hz light preserves synaptic plasticity and mitochondrial function in Alzheimer’s disease model
Sorting out the cell biology of Alzheimer’s disease: focus on BACE1 and APP
CSF levels of the BACE1 substrate NRG1 correlate with cognition in Alzheimer’s disease
Substrates and functions of the Alzheimer’s disease proteases ADAM10, BACE1, and MT5-MMP
BACE1, the Alzheimer's beta-secretase enzyme, in health and disease
Function and substrates of the Alzheimer´s disease protease BACE1
BACE1 inhibitor drugs in clinical trials for Alzheimer’s disease
The Alzheimer's disease β-secretase enzyme, BACE1
BACE1, the Alzheimer’s beta-secretase enzyme, in health and disease
Platelet BACE1 levels as a possible biomarker for Alzheimer’s disease
Stepping closer to treating Alzheimer’s disease patients with BACE1 inhibitor drugs
The role of pathological tau in synaptic dysfunction in Alzheimer’s diseases
40 Hz light preserves synaptic plasticity and mitochondrial function in Alzheimer’s disease model
Sorting out the cell biology of Alzheimer’s disease: focus on BACE1 and APP
CSF levels of the BACE1 substrate NRG1 correlate with cognition in Alzheimer’s disease
Substrates and functions of the Alzheimer’s disease proteases ADAM10, BACE1, and MT5-MMP